Global Bio-Based Adipic Acids Market Insights, Forecast to 2025
- 1.4.1 Research Process
- 1.4.2 Data Triangulation
- 1.4.3 Research Approach
- 1.4.4 Base Year
- 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
- 1.5.2 Covid-19 Impact: Commodity Prices Indices
- 1.5.3 Covid-19 Impact: Global Major Government Policy
2 Global Bio-Based Adipic Acids Quarterly Market Size Analysis
- 2.1 Bio-Based Adipic Acids Business Impact Assessment - COVID-19
- 2.1.1 Global Bio-Based Adipic Acids Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
- 2.1.2 Global Bio-Based Adipic Acids Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
- 2.2 Global Bio-Based Adipic Acids Quarterly Market Size 2020-2021
- 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
- 2.3.1 Drivers
- 2.3.2 Restraints
- 2.3.3 Opportunities
- 2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
- 3.1 Global Bio-Based Adipic Acids Quarterly Market Size by Manufacturers, 2019 VS 2020
- 3.2 Global Bio-Based Adipic Acids Factory Price by Manufacturers
- 3.3 Location of Key Manufacturers Bio-Based Adipic Acids Manufacturing Factories and Area Served
- 3.4 Date of Key Manufacturers Enter into Bio-Based Adipic Acids Market
- 3.5 Key Manufacturers Bio-Based Adipic Acids Product Offered
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Bio-Based Adipic Acids Segments, By Type
- 4.1 Introduction
- 1.4.1 Cyclohexane Oxidation
- 1.4.2 Cyclohexene Oxidation
- 4.2 By Type, Global Bio-Based Adipic Acids Market Size, 2019-2021
- 4.2.1 By Type, Global Bio-Based Adipic Acids Market Size by Type, 2020-2021
- 4.2.2 By Type, Global Bio-Based Adipic Acids Price, 2020-2021
5 Impact of Covid-19 on Bio-Based Adipic Acids Segments, By Application
- 5.1 Overview
- 5.5.1 Synthetic Lubricants
- 5.5.2 Plasticizers
- 5.5.3 Coatings
- 5.5.4 Polyurethanes
- 5.5.5 Other
- 5.2 By Application, Global Bio-Based Adipic Acids Market Size, 2019-2021
- 5.2.1 By Application, Global Bio-Based Adipic Acids Market Size by Application, 2019-2021
- 5.2.2 By Application, Global Bio-Based Adipic Acids Price, 2020-2021
6 Geographic Analysis
- 6.1 Introduction
- 6.2 North America
- 6.2.1 Macroeconomic Indicators of US
- 6.2.2 US
- 6.2.3 Canada
- 6.3 Europe
- 6.3.1 Macroeconomic Indicators of Europe
- 6.3.2 Germany
- 6.3.3 France
- 6.3.4 UK
- 6.3.5 Italy
- 6.4 Asia-Pacific
- 6.4.1 Macroeconomic Indicators of Asia-Pacific
- 6.4.2 China
- 6.4.3 Japan
- 6.4.4 South Korea
- 6.4.5 India
- 6.4.6 ASEAN
- 6.5 Rest of World
- 6.5.1 Latin America
- 6.5.2 Middle East and Africa
7 Company Profiles
- 7.1 Asahi Kasei
- 7.1.1 Asahi Kasei Business Overview
- 7.1.2 Asahi Kasei Bio-Based Adipic Acids Quarterly Production and Revenue, 2020
- 7.1.3 Asahi Kasei Bio-Based Adipic Acids Product Introduction
- 7.1.4 Asahi Kasei Response to COVID-19 and Related Developments
- 7.2 DuPont
- 7.2.1 DuPont Business Overview
- 7.2.2 DuPont Bio-Based Adipic Acids Quarterly Production and Revenue, 2020
- 7.2.3 DuPont Bio-Based Adipic Acids Product Introduction
- 7.2.4 DuPont Response to COVID-19 and Related Developments
- 7.3 Lanxess
- 7.3.1 Lanxess Business Overview
- 7.3.2 Lanxess Bio-Based Adipic Acids Quarterly Production and Revenue, 2020
- 7.3.3 Lanxess Bio-Based Adipic Acids Product Introduction
- 7.3.4 Lanxess Response to COVID-19 and Related Developments
- 7.4 Sumitomo Chemicals
- 7.4.1 Sumitomo Chemicals Business Overview
- 7.4.2 Sumitomo Chemicals Bio-Based Adipic Acids Quarterly Production and Revenue, 2020
- 7.4.3 Sumitomo Chemicals Bio-Based Adipic Acids Product Introduction
- 7.4.4 Sumitomo Chemicals Response to COVID-19 and Related Developments
- 7.5 BASF
- 7.5.1 BASF Business Overview
- 7.5.2 BASF Bio-Based Adipic Acids Quarterly Production and Revenue, 2020
- 7.5.3 BASF Bio-Based Adipic Acids Product Introduction
- 7.5.4 BASF Response to COVID-19 and Related Developments
- 7.6 DSM
- 7.6.1 DSM Business Overview
- 7.6.2 DSM Bio-Based Adipic Acids Quarterly Production and Revenue, 2020
- 7.6.3 DSM Bio-Based Adipic Acids Product Introduction
- 7.6.4 DSM Response to COVID-19 and Related Developments
- 7.7 Ascend Performance Materials
- 7.7.1 Ascend Performance Materials Business Overview
- 7.7.2 Ascend Performance Materials Bio-Based Adipic Acids Quarterly Production and Revenue, 2020
- 7.7.3 Ascend Performance Materials Bio-Based Adipic Acids Product Introduction
- 7.7.4 Ascend Performance Materials Response to COVID-19 and Related Developments
- 7.8 Invista
- 7.8.1 Invista Business Overview
- 7.8.2 Invista Bio-Based Adipic Acids Quarterly Production and Revenue, 2020
- 7.8.3 Invista Bio-Based Adipic Acids Product Introduction
- 7.8.4 Invista Response to COVID-19 and Related Developments
- 7.9 Rhodia
- 7.9.1 Rhodia Business Overview
- 7.9.2 Rhodia Bio-Based Adipic Acids Quarterly Production and Revenue, 2020
- 7.9.3 Rhodia Bio-Based Adipic Acids Product Introduction
- 7.9.4 Rhodia Response to COVID-19 and Related Developments
- 7.10 Ascend
- 7.10.1 Ascend Business Overview
- 7.10.2 Ascend Bio-Based Adipic Acids Quarterly Production and Revenue, 2020
- 7.10.3 Ascend Bio-Based Adipic Acids Product Introduction
- 7.10.4 Ascend Response to COVID-19 and Related Developments
- 7.11 Radici
- 7.11.1 Radici Business Overview
- 7.11.2 Radici Bio-Based Adipic Acids Quarterly Production and Revenue, 2020
- 7.11.3 Radici Bio-Based Adipic Acids Product Introduction
- 7.11.4 Radici Response to COVID-19 and Related Developments
- 7.12 Haili
- 7.12.1 Haili Business Overview
- 7.12.2 Haili Bio-Based Adipic Acids Quarterly Production and Revenue, 2020
- 7.12.3 Haili Bio-Based Adipic Acids Product Introduction
- 7.12.4 Haili Response to COVID-19 and Related Developments
- 7.13 Huafon
- 7.13.1 Huafon Business Overview
- 7.13.2 Huafon Bio-Based Adipic Acids Quarterly Production and Revenue, 2020
- 7.13.3 Huafon Bio-Based Adipic Acids Product Introduction
- 7.13.4 Huafon Response to COVID-19 and Related Developments
- 7.14 Shenma Industrial
- 7.14.1 Shenma Industrial Business Overview
- 7.14.2 Shenma Industrial Bio-Based Adipic Acids Quarterly Production and Revenue, 2020
- 7.14.3 Shenma Industrial Bio-Based Adipic Acids Product Introduction
- 7.14.4 Shenma Industrial Response to COVID-19 and Related Developments
- 7.15 Hualu-Hengsheng
- 7.15.1 Hualu-Hengsheng Business Overview
- 7.15.2 Hualu-Hengsheng Bio-Based Adipic Acids Quarterly Production and Revenue, 2020
- 7.15.3 Hualu-Hengsheng Bio-Based Adipic Acids Product Introduction
- 7.15.4 Hualu-Hengsheng Response to COVID-19 and Related Developments
- 7.16 Zhejiang Shuyang
- 7.16.1 Zhejiang Shuyang Business Overview
- 7.16.2 Zhejiang Shuyang Bio-Based Adipic Acids Quarterly Production and Revenue, 2020
- 7.16.3 Zhejiang Shuyang Bio-Based Adipic Acids Product Introduction
- 7.16.4 Zhejiang Shuyang Response to COVID-19 and Related Developments
- 7.17 Kailuan Group
- 7.17.1 Kailuan Group Business Overview
- 7.17.2 Kailuan Group Bio-Based Adipic Acids Quarterly Production and Revenue, 2020
- 7.17.3 Kailuan Group Bio-Based Adipic Acids Product Introduction
- 7.17.4 Kailuan Group Response to COVID-19 and Related Developments
- 7.18 Liaoyang Sinopec
- 7.18.1 Liaoyang Sinopec Business Overview
- 7.18.2 Liaoyang Sinopec Bio-Based Adipic Acids Quarterly Production and Revenue, 2020
- 7.18.3 Liaoyang Sinopec Bio-Based Adipic Acids Product Introduction
- 7.18.4 Liaoyang Sinopec Response to COVID-19 and Related Developments
- 7.19 Hongye
- 7.19.1 Hongye Business Overview
- 7.19.2 Hongye Bio-Based Adipic Acids Quarterly Production and Revenue, 2020
- 7.19.3 Hongye Bio-Based Adipic Acids Product Introduction
- 7.19.4 Hongye Response to COVID-19 and Related Developments
- 7.20 Tianli
- 7.20.1 Tianli Business Overview
- 7.20.2 Tianli Bio-Based Adipic Acids Quarterly Production and Revenue, 2020
- 7.20.3 Tianli Bio-Based Adipic Acids Product Introduction
- 7.20.4 Tianli Response to COVID-19 and Related Developments
- 7.21 Yangmei Fengxi
- 7.21.1 Yangmei Fengxi Business Overview
- 7.21.2 Yangmei Fengxi Bio-Based Adipic Acids Quarterly Production and Revenue, 2020
- 7.21.3 Yangmei Fengxi Bio-Based Adipic Acids Product Introduction
- 7.21.4 Yangmei Fengxi Response to COVID-19 and Related Developments
8 Supply Chain and Sales Channels Analysis
- 8.1 Bio-Based Adipic Acids Supply Chain Analysis
- 8.1.1 Bio-Based Adipic Acids Supply Chain Analysis
- 8.1.2 Covid-19 Impact on Bio-Based Adipic Acids Supply Chain
- 8.2 Distribution Channels Analysis
- 8.2.1 Bio-Based Adipic Acids Distribution Channels
- 8.2.2 Covid-19 Impact on Bio-Based Adipic Acids Distribution Channels
- 8.2.3 Bio-Based Adipic Acids Distributors
- 8.3 Bio-Based Adipic Acids Customers
9 Key Findings
10 Appendix
- 10.1 About Us
This report covers market size and forecasts of Bio-Based Adipic Acids, including the following market information:
Global Bio-Based Adipic Acids Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
Global Bio-Based Adipic Acids Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
Global Bio-Based Adipic Acids Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
Global Bio-Based Adipic Acids Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K MT)
Key market players
Major competitors identified in this market include Asahi Kasei, DuPont, Lanxess, Sumitomo Chemicals, BASF, DSM, Ascend Performance Materials, Invista, Rhodia, Ascend, Radici, Haili, Huafon, Shenma Industrial, Hualu-Hengsheng, Zhejiang Shuyang, Kailuan Group, Liaoyang Sinopec, Hongye, Tianli, Yangmei Fengxi, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Cyclohexane Oxidation
Cyclohexene Oxidation
Based on the Application:
Synthetic Lubricants
Plasticizers
Coatings
Polyurethanes
Other